4.7 Letter

SARS-CoV-2 RNAemia is associated with severe chronic underlying diseases but not with nasopharyngeal viral load

Related references

Note: Only part of the references are listed.
Article Immunology

Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value

David Veyer et al.

Summary: This study analyzed 58 COVID-19 patients and found that 74.1% had SARS-CoV-2 RNAemia, which correlated with disease severity. Levels of SARS-CoV-2 RNAemia were associated with severity, suggesting that it could be a potential prognostic marker for COVID-19 patients.

CLINICAL INFECTIOUS DISEASES (2021)

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Letter Medicine, General & Internal

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

Lirong Zou et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Letter Medicine, General & Internal

Detection of SARS-CoV-2 in Different Types of Clinical Specimens

Wenling Wang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Infectious Diseases

SARS-CoV-2 detection, viral load and infectivity over the course of an infection

Kieran A. Walsh et al.

JOURNAL OF INFECTION (2020)